|
業務類別
|
-- |
|
業務概覽
|
9 Meters Biopharma Inc is a clinical-stage company pioneering novel treatments for people with rare digestive diseases, gastrointestinal (GI) conditions with unmet needs, and debilitating disorders in which the biology of the gut is a contributing factor. Its pipeline includes vurolenatide, a proprietary Phase 3 long-acting glucagon-like-peptide 1 (GLP-1) agonist for short bowel syndrome (SBS) and a robust pipeline of early-stage candidates for undisclosed rare diseases and/or unmet needs. |
| 公司地址
| 4509 Creedmoor Road, Suite 600, Raleigh, NC, USA, 27612 |
| 電話號碼
| +1 919 275-1933 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.9meters.com |
| 員工數量
| 21 |
| Ms. Bethany Sensenig |
Interim Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer |
-- |
30/05/2023 |
|
|
| Dr. Mark A. Sirgo, PhD |
Chairman of the Board |
28/03/2023 |
| Mr. Y. Michael Rice |
Independent Director |
28/03/2023 |
| Dr. Lorin K. Johnson, PhD |
Independent Director |
28/03/2023 |
| Mr. Michael T. Constantino |
Independent Director |
28/03/2023 |
| Ms. Samantha Ventimiglia |
Independent Director |
28/03/2023 |
|
|
|
|
